ProBio, a global CDMO, has launched a GMP Plasmid DNA manufacturing service at its facility in Hopewell, NJ.  This new service delivers clinical-grade plasmid DNA production from cell bank to batch release in three months. This can help accelerate the development of gene and cell therapies. Located to serve both the U.S. and European markets, the Hopewell facility offers an integrated approach to manufacturing. ProBio’s process development, in-house analytical testing, method develop...